Hqm Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 10.00 K
- Company Age 5 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 1117.54%
- Profit Growth -1280.35%
- Ebitda -1929.50%
- Net Worth -1404.61%
- Total Assets 1678.87%
About Hqm Pharmaceuticals
Hqm Pharmaceuticals Private Limited (HPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 September 2019 (Five years and four months 3 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Pallavi Awasthi, Rohit Dixit, and Premshankar Awasthi serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24290MH2019PTC331058
- Company No.
331058
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Sep 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Hqm Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pallavi Awasthi  | Director | 25-Feb-2021 | Current |
| Rohit Dixit | Director | 25-Feb-2021 | Current |
| Premshankar Awasthi | Director | 27-Sep-2019 | Current |
Financial Performance of Hqm Pharmaceuticals.
Hqm Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1117.54% increase. The company also saw a substantial fall in profitability, with a 1280.35% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1404.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hqm Pharmaceuticals?
In 2021, Hqm Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hyper Internet Private LimitedRohit Dixit is a mutual person
Golden Majestic Hospitality Private LimitedPallavi Awasthi and Rohit Dixit are mutual person
Mahashiv Organics Private LimitedRohit Dixit is a mutual person
Netgen Hitech Solutions LlpPallavi Awasthi is a mutual person
- Eastern Services Network Private Limited
Pallavi Awasthi is a mutual person
- Shashi Smriti Foundation
Pallavi Awasthi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hqm Pharmaceuticals?
Unlock and access historical data on people associated with Hqm Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hqm Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hqm Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
